Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL63713 | 0.88 | TSHR (0.41) | TSHRALDH1A1THRB | |
| SCHEMBL952948 | 0.88 | TSHR (0.41) | TSHRALDH1A1THRB | |
| SCHEMBL5702010 | 0.86 | TSHR (0.38) | TSHRALDH1A1THRB | |
| SCHEMBL65534 | 0.85 | TSHR (0.42) | TSHRALDH1A1THRB | |
| SCHEMBL538063 | 0.82 | TSHR (0.50) | TSHRALDH1A1THRB | |
| SCHEMBL2028634 | 0.81 | TSHR (0.36) | TSHRALDH1A1 | |
| SCHEMBL4207433 | 0.81 | TSHR (0.40) | TSHRALDH1A1THRB | |
| SCHEMBL9559905 | 0.80 | ALDH1A1 (0.41) | TSHRALDH1A1 | |
| SCHEMBL9560048 | 0.80 | ALDH1A1 (0.41) | TSHRALDH1A1 | |
| SCHEMBL6904341 | 0.80 | TSHR (0.48) | TSHRALDH1A1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070281870-A1 | Stimuli-degradable gels | HALLIBURTON ENERGY SERVICES, INC. | 2007-12-06 | — | — | US | claimed |
| US-20240189417-A1 | SUBSTITUTION OF NUCLEOTIDE BASES IN SELF-AMPLIFYING MESSENGER RIBONUCLEIC ACIDS | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2024-06-13 | — | — | US | disclosed |
| US-20240059846-A1 | REACTIVE MICROPARTICLES AND THEIR USE TO PREPARE FUNCTIONAL HYDROGEL PARTICLES | ALLARTA LIFE SCIENCE INC (CA) | 2024-02-22 | — | — | US | disclosed |
| EP-4255965-A1 | REACTIVE MICROPARTICLES AND THEIR USE TO PREPARE FUNCTIONAL HYDROGEL PARTICLES | Allarta Life Science Inc. (CA) | 2023-10-11 | — | — | EP | disclosed |
| EP-4180057-A1 | VIRION-LIKE DELIVERY PARTICLES FOR SELF-REPLICATING RNA MOLECULES | GlaxoSmithKline Biologicals S.A. (BE) | 2023-05-17 | — | — | EP | disclosed |
| WO-2023031855-A1 | SUBSTITUTION OF NUCLEOTIDE BASES IN SELF-AMPLIFYING MESSENGER RIBONUCLEIC ACIDS | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2023-03-09 | — | — | WO | disclosed |
| US-20220192997-A1 | VIRION-LIKE DELIVERY PARTICLES FOR SELF-REPLICATING RNA MOLECULES | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2022-06-23 | — | — | US | disclosed |
| WO-2022120478-A1 | REACTIVE MICROPARTICLES AND THEIR USE TO PREPARE FUNCTIONAL HYDROGEL PARTICLES | ALLARTA LIFE SCIENCE INC. (CA) | 2022-06-16 | — | — | WO | disclosed |
| EP-4005592-A1 | VIRION-LIKE DELIVERY PARTICLES FOR SELF-REPLICATING RNA MOLECULES | GlaxoSmithKline Biologicals S.A. (BE) | 2022-06-01 | — | — | EP | disclosed |
| US-11291635-B2 | Virion-like delivery particles for self-replicating RNA molecules | GLAXOSMITHKLINE BIOLOGICAL SA (BE) | 2022-04-05 | — | — | US | disclosed |
| EP-3115061-A1 | VIRION-LIKE DELIVERY PARTICLES FOR SELF-REPLICATING RNA MOLECULES | GlaxoSmithKline Biologicals SA (BE) | 2017-01-11 | — | — | EP | disclosed |
| EP-2900783-A1 | DEHYDRATED GEL COMPOSITIONS AND METHODS OF USING THE SAME | Halliburton Energy Services, Inc. (US) | 2015-08-05 | — | — | EP | disclosed |
| US-20130195968-A1 | VIRION-LIKE DELIVERY PARTICLES FOR SELF-REPLICATING RNA MOLECULES | NOVARTIS AG (CH) | 2013-08-01 | — | — | US | disclosed |
| EP-2590676-A2 | VIRION-LIKE DELIVERY PARTICLES FOR SELF-REPLICATING RNA MOLECULES | Novartis AG (CH) | 2013-05-15 | — | — | EP | disclosed |
| WO-2012006376-A2 | VIRION-LIKE DELIVERY PARTICLES FOR SELF-REPLICATING RNA MOLECULES | NOVARTIS AG (CH) | 2012-01-12 | — | — | WO | disclosed |
| WO-2009132206-A1 | COMPOSITIONS AND METHODS FOR INTRACELLULAR DELIVERY AND RELEASE OF CARGO | LIQUIDIA TECHNOLOGIES, INC. (US) | 2009-10-29 | — | — | WO | disclosed |
| US-7306040-B1 | Stimuli-degradable gels | HALLIBURTON ENERGY SERVICES, INC. (US) | 2007-12-11 | — | — | US | disclosed |
| US-20070277981-A1 | STIMULI-DEGRADABLE GELS | HALLIBURTON ENERGY SERVICES, INC. | 2007-12-06 | — | — | US | disclosed |
| US-20070281870-A1 | Stimuli-degradable gels | HALLIBURTON ENERGY SERVICES, INC. | 2007-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240189417-A1 | SUBSTITUTION OF NUCLEOTIDE BASES IN SELF-AMPLIFYING MESSENGER RIBONUCLEIC ACIDS | NSUN2, NSUN3, RNMT | TSHR 2502/4885ALDH1A1 3328/4885THRB 2709/4885 |
| US-20240059846-A1 | REACTIVE MICROPARTICLES AND THEIR USE TO PREPARE FUNCTIONAL HYDROGEL PARTICLES | LTA, VCL, HBB | TSHR 4092/4885ALDH1A1 507/4885THRB 2111/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.